NL7316405A - - Google Patents
Info
- Publication number
- NL7316405A NL7316405A NL7316405A NL7316405A NL7316405A NL 7316405 A NL7316405 A NL 7316405A NL 7316405 A NL7316405 A NL 7316405A NL 7316405 A NL7316405 A NL 7316405A NL 7316405 A NL7316405 A NL 7316405A
- Authority
- NL
- Netherlands
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/44—Nitrogen atoms not forming part of a nitro radical
- C07D233/50—Nitrogen atoms not forming part of a nitro radical with carbocyclic radicals directly attached to said nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19722259160 DE2259160A1 (de) | 1972-12-02 | 1972-12-02 | Neue substituierte 2-phenylaminoimidazoline, deren saeureadditionssalze und verfahren zur herstellung derselben sowie ihre verwendung als arzneimittel |
Publications (1)
Publication Number | Publication Date |
---|---|
NL7316405A true NL7316405A (fr) | 1974-06-05 |
Family
ID=5863396
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NL7316405A NL7316405A (fr) | 1972-12-02 | 1973-11-30 |
Country Status (8)
Country | Link |
---|---|
JP (1) | JPS4986365A (fr) |
AT (1) | AT326118B (fr) |
AU (1) | AU6309173A (fr) |
BE (1) | BE808150A (fr) |
DE (1) | DE2259160A1 (fr) |
ES (2) | ES421068A1 (fr) |
FR (1) | FR2208671A1 (fr) |
NL (1) | NL7316405A (fr) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2636732A1 (de) * | 1976-08-14 | 1978-02-16 | Boehringer Sohn Ingelheim | Neue substituierte 2-phenylamino- imidazoline- (2), deren saeureadditionssalze, diese enthaltende arzneimittel und verfahren zur herstellung derselben |
DE2830278A1 (de) * | 1978-07-10 | 1980-01-31 | Boehringer Sohn Ingelheim | Neue substituierte 2-phenylamino-imidazoline-(2), deren saeureadditionssalze, diese enthaltende arzneimittel und verfahren zur herstellung derselben |
DE2947563A1 (de) * | 1979-11-26 | 1981-06-04 | C.H. Boehringer Sohn, 6507 Ingelheim | Neue substituierte 2-phenylamino-imidazoline-(2), deren saeureadditionssalze, diese enthaltende arzneimittel und verfahren zur herstellung derselben |
DE2949287A1 (de) * | 1979-12-07 | 1981-06-11 | C.H. Boehringer Sohn, 6507 Ingelheim | Neue substituierte 2-phenylamino-imidazoline-(2), deren saeureadditionssalze, diese enthaltende arzneimittel und verfahren zur herstellung derselben |
DE3200258A1 (de) * | 1982-01-07 | 1983-07-21 | Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München | Substituierte 1-benzoyl-2-phenylimino-imidazolidine, deren saeureadditionssalze, verfahren zu deren herstellung und diese enthaltende arzneimittel |
IT1303672B1 (it) * | 1998-07-28 | 2001-02-23 | Nicox Sa | Sali nitrati di farmaci attivi nei disordini ossei |
EP1333028A1 (fr) * | 2002-01-31 | 2003-08-06 | Boehringer Ingelheim Pharma GmbH & Co.KG | Dérivés de 2'-halo-3',5'-dialkoxyphen-1'-yl-imino-2-imidazolidine et lur utilisation pour le traitement de l'incontinence urinaire |
US6703409B2 (en) | 2002-01-31 | 2004-03-09 | Boehringer Ingelheim Pharma Gmbh & Co Kg | 2′-Halo-3′,5′-dialkoxyphen-1′-yl-imino-2-imidazolidine and the use thereof as a drug |
DK2303264T3 (en) * | 2008-06-09 | 2018-05-22 | Allergan Inc | METHODS FOR TREATING ALPHA-ADRENERG-MEDIATED CONDITIONS USING IMIDAZOLINE DERIVATIVES |
-
1972
- 1972-12-02 DE DE19722259160 patent/DE2259160A1/de active Pending
-
1973
- 1973-11-09 AT AT943273A patent/AT326118B/de not_active IP Right Cessation
- 1973-11-30 NL NL7316405A patent/NL7316405A/xx unknown
- 1973-11-30 AU AU63091/73A patent/AU6309173A/en not_active Expired
- 1973-12-01 ES ES421068A patent/ES421068A1/es not_active Expired
- 1973-12-01 ES ES421067A patent/ES421067A1/es not_active Expired
- 1973-12-01 JP JP13483173A patent/JPS4986365A/ja active Pending
- 1973-12-03 FR FR7343033A patent/FR2208671A1/fr not_active Withdrawn
- 1973-12-03 BE BE138456A patent/BE808150A/fr unknown
Also Published As
Publication number | Publication date |
---|---|
ES421067A1 (es) | 1976-04-01 |
FR2208671A1 (en) | 1974-06-28 |
BE808150A (fr) | 1974-06-04 |
DE2259160A1 (de) | 1974-06-06 |
ATA943273A (de) | 1975-02-15 |
JPS4986365A (fr) | 1974-08-19 |
AT326118B (de) | 1975-11-25 |
ES421068A1 (es) | 1976-04-16 |
AU6309173A (en) | 1975-06-05 |